Multidisciplinary training in cardiovascular engineering

项目摘要 尽管有很大的努力和许多医学上的进步，心脏病仍然是 在美国，每年四分之一的死亡是由死亡造成的。在2010年，这些问题的处理 在美国，每6美元的医疗保健支出中，疾病约占1美元。 心血管设备只会随着心血管疾病的发病率增加而增加 人口增长，人口老龄化，医疗技术继续进步。帮助满足这一要求 需求，我们需要生物医学工程师具备相应的高级多学科知识 教育和培训。拟议的T32培训计划旨在独特地教育， 培养生物医学工程方面的博士生，并在 多学科背景，具体涉及临床医生和临床医生-科学家 结束。在他们作为实习生参加前两年的博士前学习期间 明尼苏达大学S设立生物医学工程研究生项目，六人 每年的实习生将通过多种方式与强大的培训人员互动，包括 除了开始博士研究之外的独特活动： ·完成高级心脏生理学和解剖学课程(由 UMN-美敦力可见心脏实验室合作的领导者)和心血管设备 (由当地心血管设备公司专家授课)； ·完成在UMN心血管诊所之一的临床沉浸； ·参加创新系列讲座(通过UMN医疗器械中心提供)； ·参加每月的临床焦点午餐，邀请临床医生介绍具体的 心血管疾病和相关医疗器械的限制；以及 ·参加每月的职业发展午餐会，邀请演讲者发表讲话 广阔的职业机会，包括医药科技公司研发、FDA和专利法。 我们将招募一批不同的实习生，该计划将由一个 咨询委员会，以确保其在各方面的成功。我们预计由此产生的 我们学员的多学科研究和视角将使他们能够满足 通过推动未来技术进步来推动上述需求，无论是作为研发 心血管设备公司的工程师，联邦实验室的设备监管机构，或AS 教授们领导着他们自己的心血管工程学研究项目。

Project Summary In spite of great effort and many medical advances, heart disease remains the leading cause of death in the United States causing 1 in 4 deaths annually. In 2010, the treatment of these diseases accounted for about $1 of every $6 spent on healthcare in the U.S. The demand for cardiovascular devices is only going to increase as the incidence of cardiovascular diseases rises, the population ages, and medical technology continues to advance. To help meet this demand, we need biomedical engineers with the appropriate advanced multidisciplinary education and training. The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)'s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research: • complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts); • complete a clinical immersion in one of the UMN cardiovascular clinics; • attend an innovation lecture series (offered through the UMN Medical Devices Center); • attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations; and • attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law. We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.